Literature DB >> 19128387

Conjunctival melanoma and melanosis: a reappraisal of terminology, classification and staging.

Bertil Damato1, Sarah E Coupland.   

Abstract

This paper aims to stimulate debate on the terminology, classification, grading and staging of conjunctival melanosis and melanoma. We audited our results with 76 invasive conjunctival melanomas. Staging according to the sixth edition of the Tumour Node Metastasis (TNM) system did not correlate well with tumour extent and outcome. Approximately 50% of invasive melanomas were associated with 'primary acquired melanosis with atypia', a term which in our opinion underestimates the gravity of this disease. We also found deficiencies in the grading, terminology and classification of conjunctival melanocytic abnormalities. In summary, we suggest that the term 'primary acquired melanosis' be reserved for clinical diagnosis. Histologically, this abnormality can be categorized more precisely as either 'hypermelanosis' or 'conjunctival melanocytic intraepithelial neoplasia (C-MIN)'. 'Primary acquired melanosis without atypia' can be termed more accurately as 'C-MIN without atypia'. In view of the high risk of invasive melanoma, we suggest that 'primary acquired melanosis with atypia' be termed 'C-MIN' with atypia, with the more severe changes regarded as melanoma in situ. To improve objectivity in the reporting of C-MIN, we propose a scoring system based on horizontal and vertical spread and degree of severity of melanocytic atypia. We suggest that the TNM staging system for conjunctival melanoma be revised to: (i) include a Tis stage; (ii) take account of tumour size, quadrant and caruncular involvement; and (iii) improve staging of any local invasion beyond conjunctiva.

Entities:  

Mesh:

Year:  2008        PMID: 19128387     DOI: 10.1111/j.1442-9071.2008.01888.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  30 in total

1.  Primary Acquired Melanosis: Clinical, Histopathologic and Optical Coherence Tomographic Correlation.

Authors:  Yahya A Alzahrani; Smita Kumar; Hassan Abdul Aziz; Thomas Plesec; Arun D Singh
Journal:  Ocul Oncol Pathol       Date:  2015-11-12

2.  [Conjunctival malignancies].

Authors:  Claudia Auw-Hädrich; Thomas Reinhard
Journal:  Ophthalmologe       Date:  2019-10       Impact factor: 1.059

3.  A 66-year-old woman with extensive conjunctival melanosis.

Authors:  Helen Merritt; Mathieu F Bakhoum; Matthew C Sniegowski; Bita Esmaeli
Journal:  Digit J Ophthalmol       Date:  2014-05-08

Review 4.  Advances in the management of conjunctival melanoma.

Authors:  Gargi K Vora; Hakan Demirci; Brian Marr; Prithvi Mruthyunjaya
Journal:  Surv Ophthalmol       Date:  2016-06-16       Impact factor: 6.048

5.  Relationship between Conjunctival Intraepithelial Dendritic Melanocytes and Nevocytes.

Authors:  Frederick A Jakobiec; Paula Cortes Barrantes; Mary E Aronow
Journal:  Ocul Oncol Pathol       Date:  2020-02-14

Review 6.  Systemic BRAF/MEK Inhibitors as a Potential Treatment Option in Metastatic Conjunctival Melanoma.

Authors:  Joel M Mor; Ludwig M Heindl
Journal:  Ocul Oncol Pathol       Date:  2016-12-08

7.  Blue Nevi of the Ocular Surface: Clinical Characteristics, Pathologic Features, and Clinical Course.

Authors:  Ibrahim Sayed-Ahmed; Juan Carlos Murillo; Pedro Monsalve; Jan Paul Ulloa; Maria P Fernandez; James Wong; George Elgart; Anat Galor; Sander R Dubovy; Carol L Karp
Journal:  Ophthalmology       Date:  2018-03-15       Impact factor: 12.079

Review 8.  Prognostication in eye cancer: the latest tumor, node, metastasis classification and beyond.

Authors:  T Kivelä; E Kujala
Journal:  Eye (Lond)       Date:  2012-12-21       Impact factor: 3.775

Review 9.  Conjunctival melanoma and melanocytic intra-epithelial neoplasia.

Authors:  N Kenawy; S L Lake; S E Coupland; B E Damato
Journal:  Eye (Lond)       Date:  2012-12-07       Impact factor: 3.775

10.  Conjunctival Melanoma: A New Clinical and Therapeutical Approach.

Authors:  M Rodríguez-Martín; J Rodríguez-Martín; N Merino de Paz; P Contreras Ferrer; P Rocha Cabrera; B Rodríguez Martín; G Gordillo Santana; A Martín-Herrera; A Noda-Cabrera
Journal:  Case Rep Dermatol       Date:  2010-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.